Appointment booking for Dr. Timothy Flannery, MD is currently not available.Dr. Timothy Flannery, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Timothy Flannery, MD (he/him) is a Pediatric Endocrinologist in Orange, CA with over 18 years of experience. What is your opinion of Dr. Timothy Flannery, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Timothy Flannery, MD has received over $7,469 which includes payments from the following companies:
$1,388.80 from Novo Nordisk AS
$1,197.46 from Novo Nordisk Inc
$993.14 from LILLY USA, LLC
$385.64 from Abbott Laboratories
$321.24 from Dexcom, Inc.
$307.12 from Alexion Pharmaceuticals, Inc.
$262.34 from Pfizer Inc.
$259.50 from Genentech USA, Inc.
$221.92 from INSULET CORPORATION
$216.87 from Medtronic MiniMed, Inc.
$202.31 from AbbVie, Inc.
$173.71 from sanofi-aventis U.S. LLC
$170.92 from EMD Serono, Inc.
$158.19 from Arbor Pharmaceuticals, Inc.
$151.45 from Endo Pharmaceuticals Inc.
$128.84 from Animas Corporation
$125.99 from Becton, Dickinson and Company
$117.47 from Tandem Diabetes Care, Inc.
$116.96 from Sandoz Inc.
$78.72 from Ultragenyx Pharmaceutical Inc.
Payments received by Dr. Timothy Flannery, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!